One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.

Brown DB, Gonsalves CF, Yeo CJ, Witkiewicz AK, Carr BI
Oncol Rep. 2010 24 (3): 767-9

PMID: 20664985 · DOI:10.3892/or_00000919

MeSH Terms (16)

Antimetabolites, Antineoplastic Carcinoma, Pancreatic Ductal Cell Differentiation Chemoembolization, Therapeutic Cisplatin Deoxycytidine Humans Liver Neoplasms Male Middle Aged Pancreatectomy Pancreatic Neoplasms Positron-Emission Tomography Time Factors Tomography, X-Ray Computed Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: